Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1954 1
1968 1
1969 1
1972 2
1978 1
1979 1
1981 2
1983 1
1984 1
1986 2
1987 1
1989 2
1990 1
1991 1
1994 1
1995 3
1996 2
1997 2
1998 4
1999 6
2000 3
2001 3
2002 1
2003 5
2004 1
2005 4
2006 2
2007 5
2008 4
2009 1
2010 4
2011 7
2012 4
2013 5
2014 4
2015 6
2016 5
2017 8
2018 6
2019 5
2020 10
2021 2
Text availability
Article attribute
Article type
Publication date

Search Results

123 results
Results by year
Filters applied: . Clear all
Page 1
G1T48, an oral selective estrogen receptor degrader, and the CDK4/6 inhibitor lerociclib inhibit tumor growth in animal models of endocrine-resistant breast cancer.
Andreano KJ, Wardell SE, Baker JG, Desautels TK, Baldi R, Chao CA, Heetderks KA, Bae Y, Xiong R, Tonetti DA, Gutgesell LM, Zhao J, Sorrentino JA, Thompson DA, Bisi JE, Strum JC, Thatcher GRJ, Norris JD. Andreano KJ, et al. Among authors: baker jg. Breast Cancer Res Treat. 2020 Apr;180(3):635-646. doi: 10.1007/s10549-020-05575-9. Epub 2020 Mar 4. Breast Cancer Res Treat. 2020. PMID: 32130619 Free PMC article.
123 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page